.
MergerLinks Header Logo

New Deal

New Deal

Announced

ICON BIOSCIENCE INC / EYEPOINT PHARMACEUTICALS INC / Acquisition / Private / £70m

Financials

Edit Data
Transaction Value£70m
Consideration Type-
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
Icon Bioscience

target

Icon Bioscience

Eyepoint Pharmaceuticals

bidder

Eyepoint Pharmaceuticals

Sources

Edit

Tags

Edit

treatment development

biopharma

Pharmaceuticals

United States

Private

Acquisition

Friendly

Single Bidder

Synopsis

Edit

US$100 million acquisition of Icon Bioscience, Inc., a specialty biopharmaceutical company.

Service Providers (1)

Dealmakers

Hogan Lovells

legal advisors

Hogan Lovells

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US